Sign in
4

Changes in Ownership

REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-24-000123

Director sold 756 shares at $1,170.00 ($884,520)

  • Director acquired 756 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Bassler Bonnie L · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-08-15 Exercise or conversion : show line 1 in the form 10b5-1 +756 $371.40 $280,778 2,138 D
2024-08-15 Sale : show line 2 in the form 10b5-1 −756 $1,170.00 $884,520 1,382 D
Open-market sales · 756 sh · avg $1,170.00 · $884,520

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-08-15 Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −756 1,516 D
Loading xslF345X05/edgardoc.xml…